about
Desmosomal cadherins are decreased in explanted arrhythmogenic right ventricular dysplasia/cardiomyopathy patient heartsGenetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathyMutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathyA genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathyMutational analysis of the beta- and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathyAtlas of the clinical genetics of human dilated cardiomyopathyMutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy.Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis.Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy.Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies.Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population.Contribution of exome sequencing for genetic diagnostic in arrhythmogenic right ventricular cardiomyopathy/dysplasiaDifferential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseases.Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats.Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients.A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.Screening of genes encoding junctional candidates in arrhythmogenic right ventricular cardiomyopathy/dysplasia.Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey.A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity.Plakophilin 2A is the dominant isoform in human heart tissue: consequences for the genetic screening of arrhythmogenic right ventricular cardiomyopathy.Co-expression of PC2 and proenkephalin in human tumoral adrenal medullary tissuesExpression of PC2 and PC1/PC3 in human pheochromocytomasSporadic arrhythmogenic right ventricular cardiomyopathy/dysplasia due to a de novo mutationMutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain geneCharcot-Marie-Tooth features and maculopathy in a patient with Danon diseaseImpact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancyCytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsA genetic study of angiotensin I-converting enzyme levels in human semen[Genetics and dilated cardiomyopathy]Induction of angiotensin I-converting enzyme transcription by a protein kinase C-dependent mechanism in human endothelial cells[Review: genetics of familial dilated cardiomyopathy]Exome sequencing in arrhythmogenic right ventricular cardiomyopathy: a new diagnostic tool?
P50
Q21132519-446AA076-1540-46F1-BEDB-348F7DAA73EEQ24288778-B96A4108-C67E-48D1-99CF-1D774C7EE27AQ24338214-98A8680D-F7AD-4ADE-B268-09BA62250726Q24601469-495C4557-4D2F-4230-974D-1609B79944AAQ28177723-D02CD363-A6E4-482F-95B8-68A310D2E3D8Q28246768-C023D891-3A5B-4FD8-84D2-8490E0E1CA09Q34714041-BF28519B-CE47-4DC2-AC25-7B161515F310Q34910745-123C1452-9860-4C08-9866-8951F8117461Q35443492-8ADA8DC8-2FFB-4081-80FE-661D943C5B43Q35882777-6EEE220A-0E91-48B8-AD73-F59A6CFB8FBEQ36309248-DA24D4E8-F27D-48B7-AC92-063FC1A4ADCCQ36845298-587E91B3-5DEF-4B72-91AC-0B0A328ECEF9Q37058496-F53EE793-3170-4095-8E80-07B4F91758DBQ38646693-52E34003-10F7-4A16-9F5D-428171AAFAB7Q38740489-ABB7F2DD-55C9-4A84-BFE0-21952F0A56ACQ40042810-C57CA0D7-88EF-47C0-87ED-341B5AE2FAB8Q41335428-C00065C2-F410-4C84-90E3-922B7D072CABQ41713891-8E1C3638-45B6-4E89-AF87-74AD92FFBF42Q43840390-43333543-7401-466B-8BE8-38CB2CDBE4AAQ43882133-0D76DA26-02B3-41DE-B847-976400EE2075Q48000354-819265F6-3A85-48FB-A93A-F90D99A1A9D0Q50314090-FD264A45-35B8-4CD3-8B28-8147C18A7929Q51756006-E45E12EF-BFA5-4F33-989C-0FDB4C07D93AQ54384491-4812E422-CE5A-4073-8C4E-556AFB8EE63CQ57268798-3CCB1AFE-D4DA-4A0D-AE34-652AAE138EC1Q57268802-BDDBAE3D-955F-4674-9F40-3C9BCE3DA0DDQ57907064-B69D1378-2C3C-437C-A04C-0F26F1F345B8Q57907320-2D0569BA-E5CF-4C68-9E2D-C0EC330574D4Q57907322-5C224ADF-F011-4E15-81B9-1655CD1B41A1Q60017979-0DAD17B8-47EA-46FE-B4C3-E33C60A6121DQ60018974-A662832D-FB3C-4529-A8AF-46B94A2871A9Q72281773-AC2D3485-8FB0-4AEC-9F4B-B5BE6BD11155Q75206972-03B62F9D-59E9-4B08-AE9D-D8B4D107F428Q77300092-AE0EB144-D753-4B5F-8ECB-9F67C3F3ED85Q81914754-4E3C912C-EEE7-4714-8201-128A00A4FD77Q89356442-C4E6F2F6-447D-4190-99A1-D0564EA36A66
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Villard
@ast
Eric Villard
@en
Eric Villard
@es
Eric Villard
@nl
type
label
Eric Villard
@ast
Eric Villard
@en
Eric Villard
@es
Eric Villard
@nl
prefLabel
Eric Villard
@ast
Eric Villard
@en
Eric Villard
@es
Eric Villard
@nl
P106
P214
132149841862502840719
P31
P496
0000-0001-9801-7297
P735
P7859
viaf-132149841862502840719